Hedge Fund - Sivik Global Healthcare
Eli Lilly & Co (LLY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $7,433,000 | 4.02% | 9,000 | $832.09 |
| 2 | 2024 - Q4 (2024-12-31) | $11,580,000 | 6.09% | 15,000 | $828.01 |
| 3 | 2024 - Q3 (2024-09-30) | $12,846,000 | 5.43% | 14,500 | $899.05 |
| 4 | 2024 - Q2 (2024-06-30) | $13,581,000 | 4.87% | 15,000 | $799.92 |
| 5 | 2024 - Q1 (2024-03-31) | $12,447,000 | 2.91% | 16,000 | $711.67 |
| 6 | 2023 - Q4 (2023-12-31) | $8,744,000 | 3.65% | 15,000 | $583.70 |
| 7 | 2023 - Q3 (2023-09-30) | $8,057,000 | 4.07% | 15,000 | $515.29 |
| 8 | 2023 - Q2 (2023-06-30) | $8,207,000 | 1.91% | 17,500 | $419.37 |
| 9 | 2023 - Q1 (2023-03-31) | $6,868,000 | 2.95% | 20,000 | $337.26 |
| 10 | 2022 - Q4 (2022-12-31) | $6,402,000 | 3.01% | 17,500 | $354.56 |
| 11 | 2022 - Q3 (2022-09-30) | $5,659,000 | 3.14% | 17,500 | $316.83 |
| 12 | 2022 - Q2 (2022-06-30) | $6,972,000 | 3.96% | 21,502 | $300.17 |
| 13 | 2022 - Q1 (2022-03-31) | $2,864,000 | 1.18% | 10,000 | $257.36 |
| 14 | 2021 - Q4 (2021-12-31) | $7,596,000 | 3.25% | 27,500 | $253.50 |
| 15 | 2021 - Q3 (2021-09-30) | $8,087,000 | 1.93% | 35,000 | $246.81 |
| 16 | 2021 - Q2 (2021-06-30) | $9,181,000 | 1.79% | 40,000 | $200.87 |
| 17 | 2021 - Q1 (2021-03-31) | $0 | 0% | 0 | $195.61 |
| 18 | 2020 - Q4 (2020-12-31) | $5,909,000 | 2.4% | 35,000 | $149.31 |
| 19 | 2020 - Q3 (2020-09-30) | $8,141,000 | 3.5% | 55,000 | $154.77 |
| 20 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $153.50 |
| 21 | 2020 - Q1 (2020-03-31) | $4,394,000 | 1.73% | 60,000 | $137.40 |
| 22 | 2019 - Q4 (2019-12-31) | $6,572,000 | 2.43% | 50,000 | $115.91 |
| 23 | 2019 - Q3 (2019-09-30) | $6,151,000 | 3.1% | 55,000 | $111.34 |
| 24 | 2019 - Q2 (2019-06-30) | $6,093,000 | 1.47% | 55,000 | $117.76 |
| 25 | 2019 - Q1 (2019-03-31) | $9,083,000 | 3.34% | 70,000 | $121.60 |
| 26 | 2018 - Q4 (2018-12-31) | $6,365,000 | 3.43% | 55,000 | $111.71 |
| 27 | 2018 - Q3 (2018-09-30) | $7,512,000 | 2.68% | 70,000 | $99.98 |
| 28 | 2018 - Q2 (2018-06-30) | $6,826,000 | 2.62% | 80,000 | $82.13 |
| 29 | 2017 - Q2 (2017-06-30) | $0 | 0% | 0 | $81.58 |
| 30 | 2017 - Q1 (2017-03-31) | $6,729,000 | 3.13% | 80,000 | $80.10 |
| 31 | 2016 - Q4 (2016-12-31) | $2,207,000 | 1.05% | 30,000 | $74.47 |
| 32 | 2016 - Q3 (2016-09-30) | $8,026,000 | 4.04% | 100,000 | $80.04 |
| 33 | 2016 - Q2 (2016-06-30) | $3,938,000 | 1.95% | 50,000 | $75.29 |
| 34 | 2016 - Q1 (2016-03-31) | $0 | 0% | 0 | $75.67 |
| 35 | 2015 - Q4 (2015-12-31) | $3,370,000 | 1.6% | 40,000 | $82.99 |
| 36 | 2015 - Q3 (2015-09-30) | $5,021,000 | 2.43% | 60,000 | $84.42 |
The displayed share prices are average quarterly stock market prices.